Prevalence and Antimicrobial Susceptibility Pattern of Streptococcus pneumoniae at General Hospital in the Central Region of Japan from December 2013 to February 2014


Streptococcus pneumonia infection is important cause of morbidity and mortality. This study was conducted to find out the prevalence and antimicrobial susceptibility pattern of Streptococcus pneumoniae isolates at general hospitalin the central region of Japan from December 2013 to February 2014. Streptococcus pneumoniae was identified by standard laboratory procedure. Antimicrobial susceptibility testing was performed by micro dilution assay according to CLSI recommendation. One hundred fifty-three Streptococcus pneumoniae were isolated among which 80 (52.2%) were males and 73 (47.8%) were females. Nasal discharge (134%/87.6%) contributed more than other biological materials. The age incidence of (0 - 1) years, (1 - 10) years, (11 - 40) years, (41 - 60) years and >60 years age groups were 26 (17.0%), 110 (71.9%), 3 (2.0%), 10 (6.5%), and 4 (2.6%) respectively. Positive samples were received mostly from the pediatrics (137%/89.5%), respiratory medicine (12%/7.8%) and lowest from gastroenterology (1%/0.6%) and neurology (1/ 0.6%) department. Vancomycin and rifampicin were the most active antibiotics with 100% susceptibility rates. The next best were levofloxacin, penicillin G and ceftriaxone. Our study revealed that 82 Streptococcus pneumonia isolates had multidrug resistant ability (53.6%). Streptococcus pneumoniae infection spreads among community easily and inappropriate use of antibiotics contributes to their resistance. Continuous antimicrobial susceptible surveys are essential to guide policy on the adequate use of antibiotics to reduce the morbidity and mortality and reduce the emergency of antimicrobial resistance.

Share and Cite:

Minami, M. , Sakakibara, R. , Imura, T. , Morita, H. , Kanemaki, N. and Ohta, M. (2014) Prevalence and Antimicrobial Susceptibility Pattern of Streptococcus pneumoniae at General Hospital in the Central Region of Japan from December 2013 to February 2014. Journal of Biosciences and Medicines, 2, 12-17. doi: 10.4236/jbm.2014.26003.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Mitchell, A.M. and Mitchell, T.J. (2010) Streptococcus pneumoniae: Virulence Factors and Variation. Clinical Micro-biology and Infection, 16, 411-418.
[2] Lynch, J.P. and Zhanel, G.G. (2009) Streptococcus pneumoniae: Epidemiology, Risk Factors and Strategies for Prevention. Seminars in Respi-ratoryand Critical, Care Medicine, 30, 189-209.
[3] Crook, D.W., Brueggemann, A.B., Sleeman, K.L. and Peto, T.E.A. (2004) Pneumococcal Carriage. In: Tuomanen, E.I., Mitchell, T.J., Morrison, D.A. and Spratt, B.G., Eds., The Pneumococcus, American Society for Microbiology, Washington DC, 136-148.
[4] Willems, R.J.L., Hanage, W.P., Bessen, D.E. and Feil, E.J. (2011) Population Biology of Gram-Positive Pathogens: High-Risk Clones for Dissemination of Antibiotic Resistance. FEMS Microbiology Review, 35, 872-900.
[5] Clinical and Laboratory Standards Institute (CLSI) (2014) Performance Standards for Antimicrobial Susceptibility Testing: 24st Informational Supplement. Clinical and Laboratory Standards Institute M100-S24, Wayne.
[6] Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., et al. (2012) Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clinical Microbiology and In-fection, 18, 268-281.
[7] Geng, Q., Zhang, T., Ding, Y., Tao, Y., Lin, Y., Wang, Y., et al. (2014) Molecular Characterization and Antimicrobial Susceptibility of Streptococcus pneumoniae Isolated from Children Hospitalized with Respiratory Infections in Suzhou, China. PLoS One, 9, e93752.
[8] Hofman, J., Cetron, M.S. and Farley, M.M. (1995) The Prevalence of Drug Resistant Streptococcus pneumoniae in Atlanta. New England. Journal of Medicine, 333, 481-486.
[9] Kim, S.H., Song, J.H., Chung, R.D., Thamlikitkul, V., Yang, Y., Wang, H., et al. on Behalf of ANSORP Study Group (2012) Changing Trends in Antimicrobial Resistance and Serotypes of Streptococcus pneumoniae Isolates in Asian Countries: An Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Antimicrobial Agents and Chemotherapy, 56, 1418-1426.
[10] Xue, L., Yao, K., Xie, G., Zheng, Y., Wang, C., Shang, Y., et al. (2010) Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates That Cause Invasive Disease among Chinese Children. Clinical Infectious Disease, 50, 741-744.
[11] Zhao, C., Zhang, F., Chu, Y., Liu, Y., Cao, B., Chen, M., et al. (2013) Phenotypic and Genotypic Characteristic of Invasive Pneumococcal Isolates from Both Children and Adult Patients from a Multicenter Surveillance in China 2005-2011. Plos One, 8, e82361.
[12] Zhang, Y., Chen, Y., Wang, Z., Li Y., Wang, D., Shang, Y., et al. (2013) Serological and Molecular Capsular Typing, Antibiotic Susceptibility and Multilocus Sequence Typing of Streptococcus pneumoniae Isolates from Invasive and Non-Invasive Infections. Chinese Medical Journal, 126, 2296-2303.
[13] Okade, H., Funatsu, T., Eto, M., Furuya, Y., Mizunaga, S., Nomura, N., et al. (2014) Impact of the Pneumococcal Conjugate Vaccine on Serotype Distribution and Susceptibility Trends of Pediatric Non-Invasive Streptococcus pneumoniae Isolates in Tokai, Japan over a 5-Year Period. Journal of Infection and Chemotherapy.
[14] Dunais, B., Bruno-Bazureault, P., Carsenti-Dellamonica, H., Touboul, P. and Pradir, C. (2011) Adecade-Long Surveillance of Nasopharyngeal Colonization with Streptococcus pneumoniae among Children Attending Day-Care Centres in South-Eastern France: 1999-2008. European Journal of Clinical Mi-crobiology and Infection Disease, 30, 837-843.
[15] Tajima, T., Sato, T., Toyonaga, Y., Hanaki, H. and Sunakawa, K. (2013) Nationwide Survey of the Development of Drug-Resistant Pathogens in the Pediatric Field in 2007 and 2010: Drug Sensitivity of Streptococcus pneumoniae in Japan (Second Report). Journal of Infection and Chemotherapy, 19, 510-516.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.